Diabetes mellitus (DM)-induced impairment of collateral formation has been demonstrated in subjects with coronary artery disease, which contributes to unfavorable prognosis among diabetic individuals. In our previous studies, thioredoxin1 (Trx1) activity was shown to be decreased in diabetic cardiac tissues, but the reason of Trx1 inactivation and whether it mediates the impaired angiogenesis in ischemic myocardium is still to be identified. As thioredoxin-interacting protein (TXNIP), an endogenous inhibitor of Trx, is overexpressed in DM due to carbohydrate response element within its promoter, we hypothesized that inhibition of Trx1 by enhanced TXNIP expression in endothelial cells may play a role in hyperglycemia-induced impairment of angiogenesis. In the present study, we found that high glucose-mediated increase of TXNIP expression and TXNIP-Trx1 interaction induced the impairment in endothelial cell function and survival, since these detrimental effects are rescued by silencing TXNIP with small interfering RNA. In diabetic mice, TXNIP knockdown or recombinant human Trx1 treatment counteracted the impairment of angiogenesis, alleviated myocardial ischemic injury, and improved survival rate. All these data implicate that TXNIP upregulation and subsequently the increased formation of TXNIP-Trx1 complex is a novel pathologic pathway by which DM induces insufficient angiogenesis and thereby exacerbates myocardial ischemia injury.

1.
Mouquet
F
,
Cuilleret
F
,
Susen
S
,
Sautière
K
,
Marboeuf
P
,
Ennezat
PV
, et al.
.
Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1
.
Eur Heart J
.
2009
Apr
;
30
(
7
):
840
9
.
[PubMed]
0195-668X
2.
Kota
SK
,
Meher
LK
,
Jammula
S
,
Kota
SK
,
Krishna
SV
,
Modi
KD
.
Aberrant angiogenesis: the gateway to diabetic complications
.
Indian J Endocrinol Metab
.
2012
Nov
;
16
(
6
):
918
30
.
[PubMed]
2230-8210
3.
Yamawaki
H
,
Haendeler
J
,
Berk
BC
.
Thioredoxin: a key regulator of cardiovascular homeostasis
.
Circ Res
.
2003
Nov
;
93
(
11
):
1029
33
.
[PubMed]
0009-7330
4.
Whayne
TF
Jr
,
Parinandi
N
,
Maulik
N
.
Thioredoxins in cardiovascular disease
.
Can J Physiol Pharmacol
.
2015
Nov
;
93
(
11
):
903
11
.
[PubMed]
0008-4212
5.
Luan
R
,
Liu
S
,
Yin
T
,
Lau
WB
,
Wang
Q
,
Guo
W
, et al.
.
High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation
.
Cardiovasc Res
.
2009
Jul
;
83
(
2
):
294
302
.
[PubMed]
0008-6363
6.
Yin
T
,
Hou
R
,
Liu
S
,
Lau
WB
,
Wang
H
,
Tao
L
.
Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury
.
J Mol Cell Cardiol
.
2010
Sep
;
49
(
3
):
354
61
.
[PubMed]
0022-2828
7.
Dunn
LL
,
Buckle
AM
,
Cooke
JP
,
Ng
MK
.
The emerging role of the thioredoxin system in angiogenesis
.
Arterioscler Thromb Vasc Biol
.
2010
Nov
;
30
(
11
):
2089
98
.
[PubMed]
1079-5642
8.
Samuel
SM
,
Thirunavukkarasu
M
,
Penumathsa
SV
,
Koneru
S
,
Zhan
L
,
Maulik
G
, et al.
.
Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats
.
Circulation
.
2010
Mar
;
121
(
10
):
1244
55
.
[PubMed]
0009-7322
9.
Adluri
RS
,
Thirunavukkarasu
M
,
Zhan
L
,
Akita
Y
,
Samuel
SM
,
Otani
H
, et al.
.
Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice
.
J Mol Cell Cardiol
.
2011
Jan
;
50
(
1
):
239
47
.
[PubMed]
0022-2828
10.
Kaga
S
,
Zhan
L
,
Matsumoto
M
,
Maulik
N
.
Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor
.
J Mol Cell Cardiol
.
2005
Nov
;
39
(
5
):
813
22
.
[PubMed]
0022-2828
11.
Li
X
,
Kover
KL
,
Heruth
DP
,
Watkins
DJ
,
Moore
WV
,
Jackson
K
, et al.
.
New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells
.
Mol Endocrinol
.
2015
Aug
;
29
(
8
):
1184
94
.
[PubMed]
0888-8809
12.
Gao
E
,
Lei
YH
,
Shang
X
,
Huang
ZM
,
Zuo
L
,
Boucher
M
, et al.
.
A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse
.
Circ Res
.
2010
Dec
;
107
(
12
):
1445
53
.
[PubMed]
0009-7330
13.
Shi
Y
,
Vanhoutte
PM
.
Macro- and microvascular endothelial dysfunction in diabetes
.
J Diabetes
.
2017
May
;
9
(
5
):
434
49
.
[PubMed]
1753-0393
14.
Dai
S
,
He
Y
,
Zhang
H
,
Yu
L
,
Wan
T
,
Xu
Z
, et al.
.
Endothelial-specific expression of mitochondrial thioredoxin promotes ischemia-mediated arteriogenesis and angiogenesis
.
Arterioscler Thromb Vasc Biol
.
2009
Apr
;
29
(
4
):
495
502
.
[PubMed]
1079-5642
15.
Schroder
K
,
Zhou
R
,
Tschopp
J
.
The NLRP3 inflammasome: a sensor for metabolic danger
.
Science
.
2010
Jan
;
327
(
5963
):
296
300
.
[PubMed]
0036-8075
16.
Myers
RB
,
Fomovsky
GM
,
Lee
S
,
Tan
M
,
Wang
BF
,
Patwari
P
, et al.
.
Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart
.
Am J Physiol Heart Circ Physiol
.
2016
Jun
;
310
(
11
):
H1748
59
.
[PubMed]
0363-6135
17.
Ng
MK
,
Wu
J
,
Chang
E
,
Wang
BY
,
Katzenberg-Clark
R
,
Ishii-Watabe
A
, et al.
.
A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration
.
Arterioscler Thromb Vasc Biol
.
2007
Jan
;
27
(
1
):
106
12
.
[PubMed]
1079-5642
18.
Su
H
,
Ji
L
,
Xing
W
,
Zhang
W
,
Zhou
H
,
Qian
X
, et al.
.
Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein
.
J Cell Mol Med
.
2013
Jan
;
17
(
1
):
181
91
.
[PubMed]
1582-1838
19.
Kim
GS
,
Kim
BK
,
Shin
DH
,
Kim
JS
,
Hong
MK
,
Gwon
HC
, et al.;
K-CTO Registry
.
Predictors of poor clinical outcomes after successful chronic total occlusion intervention with drug-eluting stents
.
Coron Artery Dis
.
2017
Aug
;
28
(
5
):
381
6
.
[PubMed]
0954-6928
20.
Dunn
LL
,
Simpson
PJ
,
Prosser
HC
,
Lecce
L
,
Yuen
GS
,
Buckle
A
, et al.
.
A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis
.
Diabetes
.
2014
Feb
;
63
(
2
):
675
87
.
[PubMed]
0012-1797
21.
Shen
M
,
Bai
D
,
Liu
B
,
Lu
X
,
Hou
R
,
Zeng
C
, et al.
.
Dysregulated Txnip-ROS-Wnt axis contributes to the impaired ischemic heart repair in diabetic mice
.
Biochim Biophys Acta Mol Basis Dis
.
2018
Dec
;
1864
(
12
):
3735
45
.
[PubMed]
0925-4439
You do not currently have access to this content.